Howard Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.26M Buy
2,511
+961
+62% +$461K 0.02% 243
2026
Q1
$762K Sell
1,550
-1,541
-50% -$836K 0.01% 191
2025
Q4
$1.79M Buy
3,091
+16
+0.5% +$9.05K 0.02% 172
2025
Q3
$1.49M Buy
3,075
+96
+3% +$44.7K 0.02% 184
2025
Q2
$1.21M Buy
2,979
+670
+29% +$280K 0.02% 194
2025
Q1
$1.15M Sell
2,309
-352
-13% -$191K 0.03% 179
2024
Q4
$1.38M Buy
2,661
+176
+7% +$96.8K 0.02% 179
2024
Q3
$1.54M Buy
+2,485
New +$1.47M 0.03% 164

Other funds holding TMO

Howard Capital Management's TMO Position: Q2 2026 in Review

Howard Capital Management increased its Thermo Fisher Scientific (TMO) stake by 62% in Q2 2026, buying an estimated $461K and bringing the position to 2,511 shares worth $1.26M. The position accounts for 0.02% of the portfolio, ranked #243.

Howard Capital Management first reported a position in TMO in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.79M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Howard Capital Management held 2,511 shares of Thermo Fisher Scientific worth $1.26M as of Q2 2026.
  • Howard Capital Management bought 961 Thermo Fisher Scientific shares in Q2 2026, an estimated $461K.
  • Thermo Fisher Scientific made up 0.02% of Howard Capital Management's portfolio in Q2 2026, its #243 holding.
  • Howard Capital Management first reported a position in Thermo Fisher Scientific in Q3 2024 and has held it in 8 quarters since.
  • Howard Capital Management's Thermo Fisher Scientific position peaked at $1.79M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Howard Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.